These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 19374199)
1. [Suppression of hepatitis C virus with the reagent targetting host factors]. Hirata Y; Sudoh M; Kohara M Uirusu; 2008 Dec; 58(2):207-13. PubMed ID: 19374199 [TBL] [Abstract][Full Text] [Related]
2. [Suppression of hepatitis C virus (HCV) replication with serine palmitoyltransferase inhibitor]. Hirata Y; Sudoh M; Kohara M Yakugaku Zasshi; 2010 Feb; 130(2):157-61. PubMed ID: 20118637 [TBL] [Abstract][Full Text] [Related]
3. Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model. Umehara T; Sudoh M; Yasui F; Matsuda C; Hayashi Y; Chayama K; Kohara M Biochem Biophys Res Commun; 2006 Jul; 346(1):67-73. PubMed ID: 16750511 [TBL] [Abstract][Full Text] [Related]
4. A serine palmitoyltransferase inhibitor blocks hepatitis C virus replication in human hepatocytes. Katsume A; Tokunaga Y; Hirata Y; Munakata T; Saito M; Hayashi H; Okamoto K; Ohmori Y; Kusanagi I; Fujiwara S; Tsukuda T; Aoki Y; Klumpp K; Tsukiyama-Kohara K; El-Gohary A; Sudoh M; Kohara M Gastroenterology; 2013 Oct; 145(4):865-73. PubMed ID: 23791700 [TBL] [Abstract][Full Text] [Related]
5. Self-enhancement of hepatitis C virus replication by promotion of specific sphingolipid biosynthesis. Hirata Y; Ikeda K; Sudoh M; Tokunaga Y; Suzuki A; Weng L; Ohta M; Tobita Y; Okano K; Ozeki K; Kawasaki K; Tsukuda T; Katsume A; Aoki Y; Umehara T; Sekiguchi S; Toyoda T; Shimotohno K; Soga T; Nishijima M; Taguchi R; Kohara M PLoS Pathog; 2012; 8(8):e1002860. PubMed ID: 22916015 [TBL] [Abstract][Full Text] [Related]
6. Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft. Gao L; Aizaki H; He JW; Lai MM J Virol; 2004 Apr; 78(7):3480-8. PubMed ID: 15016871 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C Virus Induces the Localization of Lipid Rafts to Autophagosomes for Its RNA Replication. Kim JY; Wang L; Lee J; Ou JJ J Virol; 2017 Oct; 91(20):. PubMed ID: 28747506 [TBL] [Abstract][Full Text] [Related]
8. Host sphingolipid biosynthesis as a target for hepatitis C virus therapy. Sakamoto H; Okamoto K; Aoki M; Kato H; Katsume A; Ohta A; Tsukuda T; Shimma N; Aoki Y; Arisawa M; Kohara M; Sudoh M Nat Chem Biol; 2005 Nov; 1(6):333-7. PubMed ID: 16408072 [TBL] [Abstract][Full Text] [Related]
9. Ribonucleotide reductase M2 promotes RNA replication of hepatitis C virus by protecting NS5B protein from hPLIC1-dependent proteasomal degradation. Kitab B; Satoh M; Ohmori Y; Munakata T; Sudoh M; Kohara M; Tsukiyama-Kohara K J Biol Chem; 2019 Apr; 294(15):5759-5773. PubMed ID: 30755480 [TBL] [Abstract][Full Text] [Related]
10. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase. Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317 [TBL] [Abstract][Full Text] [Related]
11. HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus. Kneteman NM; Howe AY; Gao T; Lewis J; Pevear D; Lund G; Douglas D; Mercer DF; Tyrrell DL; Immermann F; Chaudhary I; Speth J; Villano SA; O'Connell J; Collett M Hepatology; 2009 Mar; 49(3):745-52. PubMed ID: 19072827 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts. Aizaki H; Lee KJ; Sung VM; Ishiko H; Lai MM Virology; 2004 Jul; 324(2):450-61. PubMed ID: 15207630 [TBL] [Abstract][Full Text] [Related]
13. Interaction of stomatin with hepatitis C virus RNA polymerase stabilizes the viral RNA replicase complexes on detergent-resistant membranes. Kim JH; Rhee JK; Ahn DG; Kim KP; Oh JW J Microbiol Biotechnol; 2014 Dec; 24(12):1744-54. PubMed ID: 25262680 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus replication is modulated by the interaction of nonstructural protein NS5B and fatty acid synthase. Huang JT; Tseng CP; Liao MH; Lu SC; Yeh WZ; Sakamoto N; Chen CM; Cheng JC J Virol; 2013 May; 87(9):4994-5004. PubMed ID: 23427160 [TBL] [Abstract][Full Text] [Related]
15. Resistance analysis and characterization of NITD008 as an adenosine analog inhibitor against hepatitis C virus. Qing J; Luo R; Wang Y; Nong J; Wu M; Shao Y; Tang R; Yu X; Yin Z; Sun Y Antiviral Res; 2016 Feb; 126():43-54. PubMed ID: 26724382 [TBL] [Abstract][Full Text] [Related]
16. Annexin A2 is involved in the formation of hepatitis C virus replication complex on the lipid raft. Saxena V; Lai CK; Chao TC; Jeng KS; Lai MM J Virol; 2012 Apr; 86(8):4139-50. PubMed ID: 22301157 [TBL] [Abstract][Full Text] [Related]
17. Cooperation between the Hepatitis C Virus p7 and NS5B Proteins Enhances Virion Infectivity. Aligeti M; Roder A; Horner SM J Virol; 2015 Nov; 89(22):11523-33. PubMed ID: 26355084 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of Pycnogenol® on hepatitis C virus replication. Ezzikouri S; Nishimura T; Kohara M; Benjelloun S; Kino Y; Inoue K; Matsumori A; Tsukiyama-Kohara K Antiviral Res; 2015 Jan; 113():93-102. PubMed ID: 25446333 [TBL] [Abstract][Full Text] [Related]
19. Modulation of host metabolism as a target of new antivirals. Ikeda M; Kato N Adv Drug Deliv Rev; 2007 Oct; 59(12):1277-89. PubMed ID: 17897752 [TBL] [Abstract][Full Text] [Related]
20. Chemical genetics-based discovery of indole derivatives as HCV NS5B polymerase inhibitors. Jin G; Lee S; Choi M; Son S; Kim GW; Oh JW; Lee C; Lee K Eur J Med Chem; 2014 Mar; 75():413-25. PubMed ID: 24561671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]